Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00670904 · ClinicalTrials.gov registry record · NA
Randomized Trial Assessing the Effectiveness of a Pharmacist-Delivered Program for Smoking Cessation
A NA study, sponsored by University of Montana.
- Completed
- Registry status
- NA
- Development phase
- 101
- Enrollment target
NCT00670904 is a NA study that has completed, run by University of Montana. The registered enrollment target is 101 participants.
The verdict
NCT00670904, a NA study, has completed, sponsored by University of Montana.
- COMPLETED
- Registry status
- NA
- Development phase
- 101 participants
- Enrollment target
Study Summary
This randomized trial compared the effectiveness of a three session pharmacist-delivered group program for smoking versus one 5 to 10 minute standard care session delivered over the telephone on 7-day point prevalence quit rates. Participants in both groups were offered their choice of bupropion IR or nicotine patch at no cost. At 6 months after the established quit date, self-reported cessation was biochemically verified using tests for urinary cotinine.
Interventions
- OTHER Pharmacist-delivered group program for smoking cessation
- OTHER Brief standard care session for smoking cessation delivered over the telephone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2005-10 |
| Est. Completion | 2007-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00670904
The ClinicalTrials.gov registry entry for NCT00670904 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Montana, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Pharmacist-delivered group program for smoking cessation is the first listed.
NCT00670904 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00670904 about?
NCT00670904 is a clinical study titled "Randomized Trial Assessing the Effectiveness of a Pharmacist-Delivered Program for Smoking Cessation". This randomized trial compared the effectiveness of a three session pharmacist-delivered group program for smoking versus one 5 to 10 minute standard care session delivered over the telephone on 7-day point prevalence quit rates. Participants in both groups were offered their choice of bupropion IR ...
What is the current status of trial NCT00670904?
This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2005-10. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00670904?
The interventions under investigation include: Pharmacist-delivered group program for smoking cessation (OTHER), Brief standard care session for smoking cessation delivered over the telephone (OTHER).
Who is sponsoring clinical trial NCT00670904?
This trial is sponsored by University of Montana, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.